Login / Signup

Brentuximab induced CD30+ cutaneous lymphoma responded to anti-PD1 treatment.

Vasiliki A NikolaouT IliakisL MarinosA EconomidiP PanayiotidisD RigopoulosA J Stratigos
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)
Keyphrases
  • diffuse large b cell lymphoma
  • diabetic rats
  • drug induced
  • oxidative stress
  • replacement therapy
  • smoking cessation